glp-1 compounding pharmacy Compounded Microdose GLP title π¨ Important Update on
Description
consulting fees from Eli Lilly, Boehringer Ingelheim, Gilead, Goldfinch Bio, Bayer, Novo Nordisk and AstraZeneca
Compensation might be available for lost wages if the side effects have impacted the individuals ability to work, and for future medical bills if ongoing treatment is necessary
Research shows that taking GLP-1 receptor agonists may increase a persons risk of developing certain vision problems, including NAION, which can cause sudden, painless vision loss in one eye due to reduced blood flow in the optic nerve
doi: 10.1210/endo.140.3.6550
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB, Granger CB, Jones NP, et al
